Health literacy predicts pediatric dosing accuracy for liquid zidovudine

AIDS

Volumn 28, Issue 7, 2014, Pages 1041-1048

  Howard, Leigh M ^a   Tique, José A ^b   Gaveta, Sandra ^c   Sidat, Mohsin ^c   Rothman, Russell L ^d   Vermund, Sten H ^d   Ciampa, Philip J ^a,e  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Friends in Global Health LLC   (United States)

^c EDUARDO MONDLANE UNIVERSITY   (Mozambique)

^d Department of Medicine and Pediatrics ^*  (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Africa; antiretroviral therapy; dosing errors; health literacy; HIV; prevention of mother to child HIV transmission

Indexed keywords

ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; DOSE CALCULATION; DRUG DOSAGE FORM; FEMALE; HEALTH LITERACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; MEASUREMENT ERROR; MEDICATION THERAPY MANAGEMENT; MOZAMBIQUE; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS TRANSMISSION; VISION TEST; ADOLESCENT; CAREGIVER; HIV INFECTIONS; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CAREGIVERS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH LITERACY; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MOZAMBIQUE; YOUNG ADULT; ZIDOVUDINE;

EID: 84897498908     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000197     Document Type: Article

References (80)

1. World Health Organization. Global HIV/AIDS response: epidemic update and health sector progress towards Universal Access-progress report. Geneva, Switzerland: WHO; 2011.
2. Study EC. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40:458-465.
3. Chetty T, Knight S, Giddy J, Crankshaw TL, Butler LM, Newell ML. A retrospective study of human immunodeficiency virus transmission, mortality and loss to follow-up among infants in the first 18 months of life in a prevention of mother-to-child transmission programme in an urban hospital in KwaZulu-Natal, South Africa. BMC Pediatr 2012; 12:146.
4. Joint United Nations Programme on HIV/AIDS. Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive, 2011-2015. 2011.
5. Spensley A, Sripipatana T, Turner AN, Hoblitzelle C, Robinson J, Wilfert C. Preventing mother-to-child transmission of HIV in resource-limited settings: the Elizabeth Glaser Pediatric AIDS Foundation experience. Am J Public Health 2009; 99:631-637.
6. Cooke GS, Little KE, Bland RM, Thulare H, Newell ML. Need for timely paediatric HIV treatment within primary healthcare in rural South Africa. PLoS One 2009; 4:e7101.
7. Ciaranello AL, Park JE, Ramirez-Avila L, Freedberg KA, Walensky RP, Leroy V. Early infant HIV-1 diagnosis programs in resourcelimited settings: opportunities for improved outcomes and more cost-effective interventions. BMC Med 2011; 9:59.
8. Tejiokem MC, Faye A, Penda IC, Guemkam G, Ateba Ndongo F, Chewa G, et al. Feasibility of early infant diagnosis of HIV in resource-limited settings: the ANRS 12140-PEDIACAM study in Cameroon. PLoS One 2011; 6:e21840.
9. Cook RE, Ciampa PJ, Sidat M, Blevins M, Burlison J, Davidson MA, et al. Predictors of successful early infant diagnosis of HIV in a rural district hospital in Zambezia, Mozambique. J Acquir Immune Defic Syndr 2011; 56:e104-e109.
10. Marcos Y, Phelps BR, Bachman G. Community strategies that improve care and retention along the prevention of mother-tochild transmission of HIV cascade: a review. J Int AIDS Soc 2012; 15 (Suppl 2):17394.
11. Ciampa PJ, Burlison JR, Blevins M, Sidat M, Moon TD, Rothman RL, et al. Improving retention in the early infant diagnosis of HIV program in rural Mozambique by better service integration. J Acquir Immune Defic Syndr 2011; 58:115-119.
12. Ciampa PJ, Tique JA, Juma N, Sidat M, Moon TD, Rothman RL, et al. Addressing poor retention of infants exposed to HIV: a quality improvement study in rural Mozambique. J Acquir Immune Defic Syndr 2012; 60:e46-e52.
13. Boateng D, Kwapong GD, Agyei-Baffour P. Knowledge, perception about antiretroviral therapy (ART) and prevention of mother-to-child-transmission (PMTCT) and adherence to ART among HIV positive women in the Ashanti Region, Ghana: a cross-sectional study. BMC Womens Health 2013; 13:2.
14. Mepham S, Zondi Z, Mbuyazi A, Mkhwanazi N, Newell ML. Challenges in PMTCT antiretroviral adherence in northern KwaZulu-Natal, South Africa. AIDS Care 2011; 23:741-747.
15. Kirsten I, Sewangi J, Kunz A, Dugange F, Ziske J, Jordan-Harder B, et al. Adherence to combination prophylaxis for prevention of mother-to-child- transmission of HIV in Tanzania. PLoS One 2011; 6:e21020.
16. Zandieh SO, Goldmann DA, Keohane CA, Yoon C, Bates DW, Kaushal R. Risk factors in preventable adverse drug events in pediatric outpatients. J Pediatr 2008; 152:225-231.
17. Frush KS, Luo X, Hutchinson P, Higgins JN. Evaluation of a method to reduce over-the-counter medication dosing error. Arch Pediatr Adolesc Med 2004; 158:620-624.
18. Li SF, Lacher B, Crain EF. Acetaminophen and ibuprofen dosing by parents. Pediatr Emerg Care 2000; 16:394-397.
19. Gribetz B, Cronley SA. Underdosing of acetaminophen by parents. Pediatrics 1987; 80:630-633.
20. Simon HK, Weinkle DA. Over-the-counter medications. Do parents give what they intend to give? Arch Pediatr Adolesc Med 1997; 151:654-656.
21. Institute of Medicine. Health literacy: a prescription to end confusion. Washington, DC: National Academies Press; 2004.
22. Yin HS, Dreyer BP, van Schaick L, Foltin GL, Dinglas C, Mendelsohn AL. Randomized controlled trial of a pictogrambased intervention to reduce liquid medication dosing errors and improve adherence among caregivers of young children. Arch Pediatr Adolesc Med 2008; 162:814-822.
23. Ciampa PJ, Vaz LM, Blevins M, Sidat M, Rothman RL, Vermund SH, et al. The association among literacy, numeracy, HIV knowledge and health-seeking behavior: a population-based survey of women in rural Mozambique. PLoS One 2012; 7:e39391.
24. World Health Organization. Antiretroviral therapy for HIV infection in infants and children: towards universal access. 2010.
25. Vaz P, Macassa E, Santos P, Mboa C. Manual de Tratamento da Criança com Infecção pelo HIV/SIDA em Moçambique. In: Saúde Md 2011.
26. Tique JA, Howard LM, Gaveta S, Sidat M, Rothman RL, Vermund SH, Ciampa PJ. Measuring health literacy in patients with HIV infection in Mozambique: development and validation of the HIV literacy test. Aids and Behaviour (review); 2013.
27. Yin HS, Mendelsohn AL, Wolf MS, Parker RM, Fierman A, van Schaick L, et al. Parents' medication administration errors: role of dosing instruments and health literacy. Arch Pediatr Adolesc Med 2010; 164:181-186.
28. Gorsuch RL. Factor analysis. Hillsdale, NJ: Lawrence Erlbaum Associates; 1983.
29. Yaffe SJ, Bierman CW, Cann HM, Cohen SN, Freeman J, Segal S, et al. Inaccuracies in administering liquid medication. Pediatrics 1975; 56:327-328.
30. Sobhani P, Christopherson J, Ambrose PJ, Corelli RL. Accuracy of oral liquid measuring devices: comparison of dosing cup and oral dosing syringe. Ann Pharmacother 2008; 42: 46-52.
31. Paul I, Yin HS. Out with teaspoons, in with metric units. AAP News; 2012. pp. 10-11.
32. Madlon-Kay DJ, Mosch FS. Liquid medication dosing errors. J Fam Pract 2000; 49:741-744.
33. U.S. Pharmacopeia. Teaspoon. http://www.pharmaco peia.cn/v29240/ usp29nf24s0-c1221.html. [Accessed 1 August 2013].
34. Sauvageot D, Schaefer M, Olson D, Pujades-Rodriguez M, O'Brien DP. Antiretroviral therapy outcomes in resourcelimited settings for HIV-infected children
35. Pizzo PA, Eddy J, Falloon J, Balis FM, Murphy RF, Moss H, et al. Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N Engl J Med 1988; 319:889-896.
36. Mitsuya H, Weinhold KJ, Furman PA, St Clair MH, Lehrman SN, Gallo RC, et al. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci USA 1985; 82:7096-7100.
37. Prendergast A, Bwakura-Dangarembizi MF, Cook AD, Bakeera-Kitaka S, Natukunda E, Nahirya Ntege P, et al. Hospitalization for severe malnutrition among HIV-infected children starting antiretroviral therapy. AIDS 2011; 25:951-956.
38. Koethe JR, Heimburger DC. Nutritional aspects of HIV-associated wasting in sub-Saharan Africa. Am J Clin Nutr 2010; 91:1138S-1142S.
39. Brentlinger PE, Behrens CB, Micek MA. Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa. Lancet Infect Dis 2006; 6:100-111.
40. Harries AD, Chimzizi R, Zachariah R. Safety, effectiveness, and outcomes of concomitant use of highly active antiretroviral therapy with drugs for tuberculosis in resource-poor settings. Lancet 2006; 367:944-945.
41. World Health Organization. Global HIV/AIDS response: epidemic update and health sector progress towards Universal Access-progress report. Geneva, Switzerland: WHO; 2011.
42. Study EC. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40:458-465.
43. Chetty T, Knight S, Giddy J, Crankshaw TL, Butler LM, Newell ML. A retrospective study of human immunodeficiency virus transmission, mortality and loss to follow-up among infants in the first 18 months of life in a prevention of mother-to-child transmission programme in an urban hospital in KwaZulu-Natal, South Africa. BMC Pediatr 2012; 12:146.
44. Joint United Nations Programme on HIV/AIDS. Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive, 2011-2015. 2011.
45. Spensley A, Sripipatana T, Turner AN, Hoblitzelle C, Robinson J, Wilfert C. Preventing mother-to-child transmission of HIV in resource-limited settings: the Elizabeth Glaser Pediatric AIDS Foundation experience. Am J Public Health 2009; 99:631-637.
46. Cooke GS, Little KE, Bland RM, Thulare H, Newell ML. Need for timely paediatric HIV treatment within primary healthcare in rural South Africa. PLoS One 2009; 4:e7101.
47. Ciaranello AL, Park JE, Ramirez-Avila L, Freedberg KA, Walensky RP, Leroy V. Early infant HIV-1 diagnosis programs in resourcelimited settings: opportunities for improved outcomes and more cost-effective interventions. BMC Med 2011; 9:59.
48. Tejiokem MC, Faye A, Penda IC, Guemkam G, Ateba Ndongo F, Chewa G, et al. Feasibility of early infant diagnosis of HIV in resource-limited settings: the ANRS 12140-PEDIACAM study in Cameroon. PLoS One 2011; 6:e21840.
49. Cook RE, Ciampa PJ, Sidat M, Blevins M, Burlison J, Davidson MA, et al. Predictors of successful early infant diagnosis of HIV in a rural district hospital in Zambezia, Mozambique. J Acquir Immune Defic Syndr 2011; 56:e104-e109.
50. Marcos Y, Phelps BR, Bachman G. Community strategies that improve care and retention along the prevention of mother-tochild transmission of HIV cascade: a review. J Int AIDS Soc 2012; 15 (Suppl 2):17394.
51. Ciampa PJ, Burlison JR, Blevins M, Sidat M, Moon TD, Rothman RL, et al. Improving retention in the early infant diagnosis of HIV program in rural Mozambique by better service integration. J Acquir Immune Defic Syndr 2011; 58:115-119.
52. Ciampa PJ, Tique JA, Juma N, Sidat M, Moon TD, Rothman RL, et al. Addressing poor retention of infants exposed to HIV: a quality improvement study in rural Mozambique. J Acquir Immune Defic Syndr 2012; 60:e46-e52.
53. Boateng D, Kwapong GD, Agyei-Baffour P. Knowledge, perception about antiretroviral therapy (ART) and prevention of mother-to-child-transmission (PMTCT) and adherence to ART among HIV positive women in the Ashanti Region, Ghana: a cross-sectional study. BMC Womens Health 2013; 13:2.
54. Mepham S, Zondi Z, Mbuyazi A, Mkhwanazi N, Newell ML. Challenges in PMTCT antiretroviral adherence in northern KwaZulu-Natal, South Africa. AIDS Care 2011; 23:741-747.
55. Kirsten I, Sewangi J, Kunz A, Dugange F, Ziske J, Jordan-Harder B, et al. Adherence to combination prophylaxis for prevention of mother-to-child- transmission of HIV in Tanzania. PLoS One 2011; 6:e21020.
56. Zandieh SO, Goldmann DA, Keohane CA, Yoon C, Bates DW, Kaushal R. Risk factors in preventable adverse drug events in pediatric outpatients. J Pediatr 2008; 152:225-231.
57. Frush KS, Luo X, Hutchinson P, Higgins JN. Evaluation of a method to reduce over-the-counter medication dosing error. Arch Pediatr Adolesc Med 2004; 158:620-624.
58. Li SF, Lacher B, Crain EF. Acetaminophen and ibuprofen dosing by parents. Pediatr Emerg Care 2000; 16:394-397.
59. Gribetz B, Cronley SA. Underdosing of acetaminophen by parents. Pediatrics 1987; 80:630-633.
60. Simon HK, Weinkle DA. Over-the-counter medications. Do parents give what they intend to give? Arch Pediatr Adolesc Med 1997; 151:654-656.
61. Institute of Medicine. Health literacy: a prescription to end confusion. Washington, DC: National Academies Press; 2004.
62. Yin HS, Dreyer BP, van Schaick L, Foltin GL, Dinglas C, Mendelsohn AL. Randomized controlled trial of a pictogrambased intervention to reduce liquid medication dosing errors and improve adherence among caregivers of young children. Arch Pediatr Adolesc Med 2008; 162:814-822.
63. Ciampa PJ, Vaz LM, Blevins M, Sidat M, Rothman RL, Vermund SH, et al. The association among literacy, numeracy, HIV knowledge and health-seeking behavior: a population-based survey of women in rural Mozambique. PLoS One 2012; 7:e39391.
64. World Health Organization. Antiretroviral therapy for HIV infection in infants and children: towards universal access. 2010.
65. Vaz P, Macassa E, Santos P, Mboa C. Manual de Tratamento da Criança com Infecção pelo HIV/SIDA em Moçambique. In: Saúde Md 2011.
66. Tique JA, Howard LM, Gaveta S, Sidat M, Rothman RL, Vermund SH, Ciampa PJ. Measuring health literacy in patients with HIV infection in Mozambique: development and validation of the HIV literacy test. Aids and Behaviour (review); 2013.
67. Yin HS, Mendelsohn AL, Wolf MS, Parker RM, Fierman A, van Schaick L, et al. Parents' medication administration errors: role of dosing instruments and health literacy. Arch Pediatr Adolesc Med 2010; 164:181-186.
68. Gorsuch RL. Factor analysis. Hillsdale, NJ: Lawrence Erlbaum Associates; 1983.
69. Yaffe SJ, Bierman CW, Cann HM, Cohen SN, Freeman J, Segal S, et al. Inaccuracies in administering liquid medication. Pediatrics 1975; 56:327-328.
70. Sobhani P, Christopherson J, Ambrose PJ, Corelli RL. Accuracy of oral liquid measuring devices: comparison of dosing cup and oral dosing syringe. Ann Pharmacother 2008; 42: 46-52.
71. Paul I, Yin HS. Out with teaspoons, in with metric units. AAP News; 2012. pp. 10-11.
72. Madlon-Kay DJ, Mosch FS. Liquid medication dosing errors. J Fam Pract 2000; 49:741-744.
73. U.S. Pharmacopeia. Teaspoon. http://www.pharmaco peia.cn/v29240/ usp29nf24s0-c1221.html. [Accessed 1 August 2013].
74. Sauvageot D, Schaefer M, Olson D, Pujades-Rodriguez M, O'Brien DP. Antiretroviral therapy outcomes in resourcelimited settings for HIV-infected children
75. Pizzo PA, Eddy J, Falloon J, Balis FM, Murphy RF, Moss H, et al. Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N Engl J Med 1988; 319:889-896.
76. Mitsuya H, Weinhold KJ, Furman PA, St Clair MH, Lehrman SN, Gallo RC, et al. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci USA 1985; 82:7096-7100.
77. Prendergast A, Bwakura-Dangarembizi MF, Cook AD, Bakeera-Kitaka S, Natukunda E, Nahirya Ntege P, et al. Hospitalization for severe malnutrition among HIV-infected children starting antiretroviral therapy. AIDS 2011; 25:951-956.
78. Koethe JR, Heimburger DC. Nutritional aspects of HIV-associated wasting in sub-Saharan Africa. Am J Clin Nutr 2010; 91:1138S-1142S.
79. Brentlinger PE, Behrens CB, Micek MA. Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa. Lancet Infect Dis 2006; 6:100-111.
80. Harries AD, Chimzizi R, Zachariah R. Safety, effectiveness, and outcomes of concomitant use of highly active antiretroviral therapy with drugs for tuberculosis in resource-poor settings. Lancet 2006; 367:944-945.